跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,372 条关于
“Hereditary Haemorrhagic Telangiectasia”
全部
2,372
临床试验
1,877
药物
50
机构
4
资讯
441
3个月前
Vaderis Raises $152 Million to Fund Phase 3 Trial of AKT Inhibitor Engasertib in Hereditary Haemorrhagic Telangiectasia
上个月
Menarini Asia-Pacific to Commercialise Cosela (trilaciclib) Across Multiple APAC Markets, First Launch Anticipated in Hong Kong in 2028
9个月前
Engasertib Shows Promise in First Controlled Trial for Hereditary Hemorrhagic Telangiectasia
2个月前
Vaderis Launches Global Phase 3 HEROIC Trial of Engasertib for Hereditary Hemorrhagic Telangiectasia
去年
Diagonal Therapeutics' DIAG723 Shows Disease-Modifying Potential for Hereditary Hemorrhagic Telangiectasia in Preclinical Studies
2年前
Vaderis' VAD044 Shows Promise in Hereditary Hemorrhagic Telangiectasia Trial
2年前
Pomalidomide Shows Promise in Reducing Bleeding for Hereditary Hemorrhagic Telangiectasia
3个月前
Atavistik Bio Secures FDA IND Clearance and Fast Track Designation for ATV-1601 in Hereditary Hemorrhagic Telangiectasia
去年
Vaderis' VAD044 Receives FDA Fast Track Designation for Hereditary Hemorrhagic Telangiectasia
去年
EMA Recommends First Vaccine Against Epizootic Haemorrhagic Disease for Cattle in EU
第 1 页，共 45 页
上一页
下一页
